Tag: cancer
GSK and Lyell Immunopharma join forces to develop the next generation...
Collaboration will combine Lyell’s technologies with GSK’s pipeline of cell therapies and manufacturing capability
LONDON, UK and SAN FRANCISCO, CA, USA I October 08,...
Immunotherapy gel targets lingering tumor cells after surgery
Sprayable gel unleashes antibodies at surgery sites to prevent cancer recurrence and metastasis
Malignant cells often get left behind when a tumor is removed during...
Cancer immune therapy developed from ‘miraculous’ recovery patients
A new immune therapy developed from “miraculous” cases of cancer recovery could be tested on human patients next year. The treatment uses cancer-killing immune...
FDA Grants Breakthrough Therapy Designation to Novartis’s CAR-T Cell Therapy CTL019
The FDA granted a breakthrough therapy designation to Novartis’s CTL019, a chimeric antigen receptor T cell immunotherapy, or CAR-T, for the treatment of adult...
University of Montreal researchers excited over possible cancer treatment breakthrough
Research being done at the Universite de Montreal has a breakthrough that was once thought unlikely now on the horizon: a vaccine for cancer.
“I’m...
Affimed and MD Anderson Announce Clinical Immuno-Oncology Development Collaboration
Agreement Brings Together MD Anderson’s Natural Killer Cell and Affimed’s Antibody-based Technologies
Affimed N.V. (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing...
Using epigenetics to help the immune system fight ovarian cancer –...
Immunotherapy, a cancer treatment approach that’s decades old, has become the hottest subject in oncology. In the past few years, researchers have developed a...
PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers
LAGUNA HILLS, Calif., Dec. 27, 2016 - PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
Fred Hutch announces $1M in grants to commercialize cutting-edge cancer and...
Fred Hutchinson Cancer Research Center, which has spun-out companies such as Juno Therapeutics and Nohla Therapeutics in recent years, is continuing its aggressive push to...
